摘要
目的探讨血清中总前列腺特异性抗原(TPSA)、血清游离PSA(FPSA)与TPSA比值(F/T)及PSA密度(PSAD)在前列腺癌诊断中的意义。方法对50例健康体检男性、467例良性前列腺增生症(BPH)及116例前列腺癌患者TPSA、F/T及PSAD值的差异进行分析、比较。结果血清TPSA值前列腺癌组(53.26±33.10)高于BPH组(8.12±9.70)及对照组(1.51±1.17);PSAD值前列腺癌组[(1.59±1.46)ng·ml^-1·cm^-3]高于BPH组[(0.14±0.17)ng·ml^-1·cm^-3]及对照组[(0.08±O.07)ng·ml^-1·cm^-3];而F/T值前列腺癌组(0.22±0.16)低于BPH组(0.27±0.15)及对照组(0.36±0.14),差异均有统计学意义(P值均〈0.01)。PSA处于4~10ng/ml时,前列腺癌组F/T(0.18±0.13)显著低于BPH组(0.27±0.14)(P〈0.05);前列腺癌组PSAD[(0.21±0.07)ng·ml^-1·cm^-3]显著高于BPH组[(0.11±0.06)ng·ml^-1·cm^-3](P〈0.001)。取F/T值0.16、PSAD值0.15ng·ml^-1·cm^-3为临界值时,F/T、PSAD值灵敏度、特异度及阳性预测值分别为81.6%、78.2%、96.1%和53.8%、76.9%、97.9%,诊断效率最高。结论F/T、PSAD是诊断前列腺癌的良好指标,当PSA为4-10ng/ml诊断灰区时,F/T与PSAD对诊断前列腺癌有较好的价值。
Objective To investigate the diagnostic value of serum TPSA, the ratio of free PSA(FPSA) and TPSA(F/T) and PSAD in prostate cancer(PCa). Methods The serum TPSA and PSAD levels and the ratio of F/T of 467 patients with BPH, 116 patients with PCa and 50 healthy men as normal control were determined, analyzed and compared. Results Serum TPSA of PCa (53.26±33.10) were significantly higher than that of BPH (8.12±9.70) (P 〈0.01), and normal control (1.51±1.17) (P 〈0.01); Serum PSAD of PCa [(1.59±l.46) ng'ml-l'cm-3] were significantly higher than that of BPH [(0.14±0.17) ng·ml^-l·cm^-3] (P 〈0.01), and normal control [(0.08±0.07) ng·ml^-1·cm^-3] (P 〈0.01); F/T of PCa (0.22±0.16) was significantly lower than that of BPH (0.27±0.15) and normal control (0.36±0.14) (P 〈0.01). When TPSA was limited specificity at 4 10 ng/ml, F/T of PCa (0.18±0.13) were significantly lower than that of BPH (0.27±0.14), (P 〈0.05), PSAD of Pca [(0.21±0.07) rig. m1^-1. cm^-3] were significantly higher than that of BPH [(0.11±0.06) ng·ml^-1·cm^-3], (P 〈 0.001). When F/T was 0.16, PSAD used 0.15 as the critical value, the sensitivity, specificity of diagnostic value and positive prediction value were 81.6 %, 78.2 %, 96.1% and 53.8 %, 76.9 %, 97.9 %, respectively; And the diagnostic efficiency was the highest. Conclusion F/T and PSAD have valuable role as the diagnose marker of PCa. When PSA level between 4 ng/ml and 10 ng/ml, F/T ratio and PSAD are of significant value to differentiate PCa from BPH patients.
出处
《肿瘤研究与临床》
CAS
2011年第2期111-113,共3页
Cancer Research and Clinic
关键词
前列腺肿瘤
前列腺特异性抗原
前列腺增生
诊断
Prostatic neoplasms
Prostate specific antigen
Prostate hyperplasia
Diagnosis